Balchem Stock Forecast for 2023 - 2025 - 2030
Updated on 12/06/2023
Balchem Stock Forecast and Price Target
If the average 2023 price target of $150.00 recently set by two prominent experts for Balchem is met, there would be a potential upside of approximately 17.17% from the last closing price in December, 2023. The high estimate is $150.00, and the low is $135.00. If you're looking for Balchem (BCPC) stock information, you might also want to check out Celanese Corp (NYSE:CE).
17.17% Upside
Balchem Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's Price has grown, increasing from $98.00 to $123.80 – a growth of 26.33%. According to 2 analysts, Balchem's Fair Value will fall by 7.20% in the next year, reaching $114.89. Professionals believe that By 2030, Balchem's Fair Value will fall to $121.64 – a 1.74% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAS Stock Forecast | BASF | Hold |
11
|
43.60€ | Buy/Sell | 48.98€ | 7.80% |
| CE Stock Forecast | Celanese Corp | Outperform |
13
|
$140.00 | Buy/Sell | $135.06 | -3.57% |
| 2802 Stock Forecast | Ajinomoto | Outperform |
18
|
¥5.50k | Buy/Sell | ¥0.00 | 16.34% |
| EMN Stock Forecast | Eastman Chemical Co | Outperform |
11
|
$83.57 | Buy/Sell | $89.51 | 1.71% |
| EVK Stock Forecast | Evonik Industries | Outperform |
18
|
17.43€ | Buy/Sell | 20.39€ | 14.74% |
Balchem Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's Revenue has grown, increasing from $643.71M to $942.36M – a growth of 46.40%. According to 3 analysts, Balchem's Revenue will fall by 1.36% in the next year, reaching $929.50M. Over the next eight years, experts anticipate that Balchem's Revenue will grow at a rate of 6.38%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600299 Stock Forecast | Bluestar Adisseo | Outperform |
18
|
¥7.73 | Buy/Sell | ¥0.00 | 41.01% |
| 000830 Stock Forecast | Luxi Chemical Group | Buy |
16
|
¥9.69 | Buy/Sell | ¥26.22 | 34.16% |
| 300705 Stock Forecast | Hunan Jiudian Pharmaceutical | Buy |
16
|
¥32.71 | Buy/Sell | ¥0.00 | -100.00% |
.jpg)
Balchem Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's Dividend per Share has grown by 36.54%, from $0.52 to $0.71. In the following year, 0 experts forecast that Balchem's Dividend per Share will decrease by 9.86%, to $0.64. In 2030, professionals predict that Balchem's Dividend per Share will decrease by 9.26%, to $0.64.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HWKN Stock Forecast | Hawkins | Outperform |
18
|
$64.25 | Buy/Sell | $52.00 | 15.18% |
| UAN Stock Forecast | CVR Partners, LP | - |
17
|
$67.01 | Buy/Sell | $9.50 | -100.00% |
| LXU Stock Forecast | LSB Industries | Outperform |
13
|
$8.74 | Buy/Sell | $12.63 | 28.72% |
Balchem Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's Free Cash Flow has decreased from $96.05M to $88.25M – a 8.12% drop. For next year, analysts predict Free Cash Flow of $114.30M, which would mean an increase of 29.52%. Over the next eight years, experts predict that Balchem's Free Cash Flow will grow at a rate of 52.68%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GNC Stock Forecast | Greencore Group | Outperform |
15
|
£0.96 | Buy/Sell | £1.43 | 4.17% |
| ACT Stock Forecast | AlzChem Group | Buy |
18
|
25.10€ | Buy/Sell | 31.35€ | 26.49% |
| AMTX Stock Forecast | Aemetis Inc | Outperform |
10
|
$4.53 | Buy/Sell | $0.00 | 65.56% |
Balchem Net Income Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's Net Income has grown from $79.67M to $105.37M – a 32.26% increase. Next year, analysts are expecting Net Income to reach $121.38M – an increase of 15.19%. Over the next eight years, the forecast is for Net Income to grow by 17.57%.
Balchem EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's EBITDA has grown by 31.47%, rising from $150.41M to $197.74M. For next year, analysts predict EBITDA of $233.60M, which would mean an increase of 18.13%. Over the next eight years, experts predict that Balchem's EBITDA will grow at a rate of 20.38%.
Balchem EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's EBIT has grown, rising from $104.83M to $146.23M – a growth of 39.49%. In the next year, analysts believe that EBIT will reach $164.36M – an increase of 12.40%. For the next eight years, the forecast is for EBIT to grow by 17.67%.
Balchem EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Balchem's EPS has grown, increasing from $3.19 to $4.03 – a growth of 26.33%. According to 2 analysts, Balchem's EPS will fall by 7.20% in the next year, reaching $3.74. Professionals believe that By 2030, Balchem's EPS will fall to $3.96 – a 1.74% decrease from its current value.
.jpg)